Clopidogrel and thrombotic thrombocytopenic purpura

الملخص EN

Clopidogrel has replaced ticlopidine (in the united states but not worldwide).

Clopidogrel can either be used independently or in combination with other antiplatelet agents.

Clopidogrel has a lower frequency of associated thrombotic thrombocytopenic purpura than ticlopidine, a lower rate of neutropenia, and better jjastroi'itestoaJLipJerance.

We, describe a case of thrombotic tlvombocytopemr, purpura in a patient 20 days after the start of clopidogrel treatment.

All symptoms are reversed with cessation of clopidogrel.

Clinicians should be alert to this adverse effect of clopidogrel and monitor platelet counts in patients receiving it.